Particle.news

Download on the App Store

UK’s First Accredited Metagenomics Service Saves Vision and Launches Clinical Trials

A pioneering genetic test identified a rare leptospirosis infection in Dr Ellie Irwin, restoring her sight and marking a breakthrough in diagnosing hard-to-detect eye infections.

Image
Image
Image

Overview

  • Dr Ellie Irwin faced potential eye removal after five years of undiagnosed chronic eye inflammation caused by a rare bacterial infection.
  • The metagenomics team at Great Ormond Street Hospital identified a specific strain of leptospirosis using an untargeted genetic test, enabling targeted treatment.
  • A three-week course of antibiotics restored Dr Irwin’s vision in time for her wedding earlier this year, marking a life-changing outcome.
  • The GOSH/UCL metagenomics service, developed over a decade, is now the UK’s first accredited platform, processing six patient samples weekly.
  • A clinical trial has been initiated to expand the use of metagenomic diagnostics for hard-to-diagnose ocular infections, building on this success.